Related Experiment Video
Updated: Jul 7, 2026
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Massive pulmonary embolism: what level of aggression?
1Department of Cardiology and Pulmonary Medicine, Georg August University of Goettingen, Goettingen, Germany. skonstan@med.uni-goettingen.de
Seminars in Respiratory and Critical Care Medicine
|February 28, 2008
Summary
Massive pulmonary embolism (PE) requires aggressive treatment. Thrombolytic therapy is indicated for hemodynamically unstable patients, but its role in submassive PE remains controversial.
Area of Science:
- Cardiology
- Pulmonology
- Emergency Medicine
Background:
- Massive pulmonary embolism (PE) carries a high mortality rate (>50%), especially with hemodynamic instability.
- Submassive PE with right ventricular (RV) dysfunction presents a controversial treatment landscape regarding thrombolysis.
- Current guidelines often do not recommend thrombolytic therapy for normotensive patients without RV dysfunction.
Purpose of the Study:
- To review indications for thrombolysis in massive PE.
- To emphasize recent data on thrombolysis in normotensive PE patients.
- To propose a diagnostic and therapeutic algorithm for acute PE management.
Main Methods:
- Review of existing literature on thrombolytic therapy for PE.
- Emphasis on recent data concerning normotensive PE patients.
- Development of a proposed diagnostic and therapeutic algorithm.
Main Results:
- Thrombolytic agents (streptokinase, urokinase, rtPA) show similar efficacy in massive PE.
- The benefit of thrombolytic therapy over heparin alone in submassive PE is not definitively established.
- The utility of imaging (echocardiography, CT) and biomarkers in guiding thrombolysis decisions is debated.
Conclusions:
- Aggressive thrombolytic therapy is crucial for hemodynamically unstable massive PE patients.
- Further research is needed to clarify the role and safety of thrombolysis in specific PE patient subgroups.
- A structured diagnostic and therapeutic approach is proposed for acute PE management.
Related Concept Videos
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...